(Total Views: 141)
Posted On: 10/22/2019 11:00:42 AM
Post# of 106694

$JAGX News Article - Jaguar Health's Study Shows Mytesi (Crofelemer) May Support Treatment of Diarrhea in Cancer Patients Receiving Targeted Therapy While Also Enabling Maintenance and Tolerability of a Higher Dose of the Selected TKI https://marketwirenews.com/news-releases/jagu...93138.html


My Twitter: WhyteStocks